Further evaluation is required to determine the validity of the observed reduction in infection-related deaths in patients treated with interferon gamma. (Arch Surg. 1994;129:1031-1041).
|Original language||English (US)|
|Number of pages||11|
|Journal||Archives of Surgery|
|State||Published - Jan 1 1994|
ASJC Scopus subject areas